Hamostaseologie 1997; 17(03): 161-162
DOI: 10.1055/s-0038-1659983
Originalarbeiten/Original Articles
Schattauer GmbH

Antithrombotic Therapy for DVT/PE

Thomas M. Hyers
1   Saint Louis University School of Medicine St. Louis, U.S.A.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Juni 2018 (online)

Preview

Summary

Problems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.